Back

Self-Organized Vascularized Cardiac Microtissues Derived from Human iPS Cells Promote Myocardial Repair through Functional Host-Graft Vascular Integration

Hakamada, K.; Murata, K.; Maihemuti, W.; Minatoya, K.; Masumoto, H.

2026-02-09 bioengineering
10.64898/2026.02.04.703917 bioRxiv
Show abstract

ObjectivesCardiac regenerative therapy using human induced pluripotent stem cell (hiPSC)-derived tissues and organoids holds great promise for treating heart diseases. Successful clinical translation requires biomimetic cardiac tissues that not only recapitulate native myocardial architecture but also actively integrate with host vasculature. We aimed to engineer self-organized, vascularized cardiac microtissues (VCMs) and evaluate their therapeutic and regenerative potential in a rat model of myocardial infarction (MI). MethodsVCMs composed of hiPSC-derived cardiomyocytes, vascular endothelial cells, and vascular mural cells were cultured under dynamic conditions to promote self-organization and prevascular network formation. One week after MI induction by coronary artery ligation in athymic immunodeficient rats, VCMs were transplanted onto the infarcted myocardium. Cardiac function was assessed by echocardiography and magnetic resonance imaging. Three-dimensional host-graft vascular architecture was visualized by light-sheet fluorescence microscopy following tissue clearing, and functional perfusion was evaluated by intravenous DyLight 488-conjugated lectin injection via host systemic circulation prior to tissue harvest. ResultsVCM transplantation significantly improved cardiac function and reduced infarct size compared with controls. Histological analyses demonstrated enhanced graft survival and neovascularization. Three-dimensional imaging revealed human-derived self-organized vascular networks within engrafted VCMs. Lectin perfusion confirmed functionally perfused, reciprocal host-graft vascular integration, including extension of graft-derived vessels into host myocardium, accompanied by myocardial regeneration. Early graft engraftment was significantly higher in the VCM group than in non-prevascularized controls. ConclusionsSelf-organized prevascularization of hiPSC-derived cardiac microtissues enable active host-graft vascular integration through functional vascular networks, thereby enhancing myocardial regeneration and therapeutic efficacy. This strategy represents an advanced approach for cardiac regenerative medicine. SummaryThis study aimed to develop self-organized, vascularized cardiac microtissues (VCMs) derived from human induced pluripotent stem cells (hiPSCs) and to evaluate their myocardial regenerative potential in a rat model of myocardial infarction (MI). VCMs were engineered from hiPSC-derived cardiomyocytes, endothelial cells, and vascular mural cells and cultured under dynamic conditions to enable self-organization and prevascular network formation. One week after MI induction, VCMs were transplanted onto the infarcted myocardium. Cardiac function was evaluated using echocardiography and magnetic resonance imaging. Light-sheet fluorescence microscopy combined with tissue clearing was used to visualize three-dimensional vascular architecture and host-graft integration, while lectin perfusion analysis assessed functional blood flow. VCM transplantation significantly improved cardiac function, increased early graft engraftment, and enhanced neovascularization. Importantly, self-organized human-derived vascular networks within the VCMs actively integrated with the host vasculature, forming functional, perfused host-graft vascular connections. These findings indicate that prevascularized VCMs do not merely survive after transplantation but actively promote vascular integration and myocardial regeneration through functional vascular networks. Together, these results demonstrate that self-organized vascularization markedly enhances graft integration, survival, and therapeutic efficacy, underscoring the clinical potential of VCM-based strategies for cardiac regenerative therapy.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Stem Cell Research & Therapy
30 papers in training set
Top 0.1%
12.0%
2
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 0.2%
12.0%
3
npj Regenerative Medicine
21 papers in training set
Top 0.1%
6.6%
4
Cytotherapy
14 papers in training set
Top 0.1%
6.2%
5
PLOS ONE
4510 papers in training set
Top 30%
6.1%
6
Tissue Engineering Part A
15 papers in training set
Top 0.1%
4.2%
7
Biomaterials
78 papers in training set
Top 0.2%
3.5%
50% of probability mass above
8
Scientific Reports
3102 papers in training set
Top 39%
3.5%
9
Stem Cells Translational Medicine
11 papers in training set
Top 0.1%
3.0%
10
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 0.9%
2.4%
11
Advanced Science
249 papers in training set
Top 8%
2.4%
12
Acta Biomaterialia
85 papers in training set
Top 0.5%
1.6%
13
Bioactive Materials
18 papers in training set
Top 0.5%
1.6%
14
Advanced Healthcare Materials
71 papers in training set
Top 1%
1.4%
15
Journal of Molecular and Cellular Cardiology
39 papers in training set
Top 0.5%
1.4%
16
Stem Cell Reports
118 papers in training set
Top 0.6%
1.3%
17
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.3%
1.3%
18
Biofabrication
32 papers in training set
Top 0.5%
1.3%
19
JACC: Basic to Translational Science
15 papers in training set
Top 0.3%
1.2%
20
BMC Cardiovascular Disorders
14 papers in training set
Top 1%
1.2%
21
Advanced Functional Materials
41 papers in training set
Top 2%
1.2%
22
Journal of Biomedical Materials Research Part A
18 papers in training set
Top 0.3%
1.2%
23
Circulation
66 papers in training set
Top 2%
1.2%
24
Molecular Therapy
71 papers in training set
Top 2%
0.9%
25
Journal of the American Heart Association
119 papers in training set
Top 4%
0.9%
26
Ultrasound in Medicine & Biology
10 papers in training set
Top 0.4%
0.9%
27
Nature Communications
4913 papers in training set
Top 60%
0.9%
28
Bioengineering
24 papers in training set
Top 1%
0.9%
29
Biomaterials Advances
20 papers in training set
Top 0.6%
0.8%
30
Annals of Biomedical Engineering
34 papers in training set
Top 1%
0.7%